FEATURED

Drug Showcase: KYROLIS (carfilzomib)

This slideshow reviews drug information for KYROLIS (carfilzomib), indicated for refractory multiple myeloma.

CancerLinQ Set to Launch in 2015

CancerLinQ will go live later this year, ushering in what they described as a transformative era of big data–driven precision cancer care.

Multiple myeloma: Optimal management

New strategies to combat myeloma incorporate risk stratification.

ASCO: Cancer Advance of the Year

The transformation of the treatment of chronic lymphocytic leukemia wins the Society's accolade.

Genetic, Metabolic Factors in RCC

Recent studies reveal the mechanisms underlying RCC and suggest new therapeutic targets.

Reflecting on Treatment for Leukemia

Dr. Cunningham: Leukemia is sometimes a solid and invasive neoplasm, but this is forgotten when leukemia is viewed as only a "liquid" cancer.

Anticoagulation from Brain Tumors

Patients with brain cancer are at increased risk of deep vein thrombosis and consequently pulmonary embolism.

New Results for Glioblastoma Drug

Phase 2 studies show in vitro effectiveness in various glioblastoma multiforme cell lines, independent of MGMT activity.

Prostate Cancer in Young Patients

Researchers seek better understanding of prostate cancer in young patients.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

CancerLinQTM Enrolls Practices, Prepares to Usher in 'Big Data Oncology' Era

CancerLinQTM Enrolls Practices, Prepares to Usher in 'Big Data Oncology' Era

ASCO's CancerLinQ go live later this year, ushering in what they described as a transformative era of big data-driven precision cancer care.

ASCO Announces Chronic Leukemia Treatment as Cancer Advance of the Year

ASCO Announces Chronic Leukemia Treatment as Cancer Advance of the Year

The transformation of the treatment of chronic lymphocytic leukemia wins the Society's accolade.

Feature Articles

Multiple myeloma: Optimal management and long-term disease control

Multiple myeloma: Optimal management and long-term disease control

[Blood and Lymphatic Cancer: Targets and Therapy] Myeloma displays considerable heterogeneity and, over time, control of disease can be lost. New strategies to combat myeloma incorporate risk stratification to provide more individualized therapy.

Reflecting on Treatment Strategies for Acute Leukemia

Reflecting on Treatment Strategies for Acute Leukemia

Leukemia is sometimes a solid, metastatic, and invasive neoplasm, but this is forgotten when leukemia is viewed as only a "liquid" cancer.

Featured Videos

Fall Digital Issue

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs